ArticleCancer cell international2022

Activation of the chemokine receptor 3 pathway leads to a better response to immune checkpoint inhibitors in patients with metastatic urothelial carcinoma.

Wenqin Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.